top of page
  • Jonathan Poyer

Biotech Private and Public Deal Highlights: 10/14/2022


Let's take a look at some highlights from the Biotech and MedTech/Diagnostics Private and Public Capital Markets and SPAC Activity Through The Week Ended October 14, 2022.


Week ending 10/14/2022:

  • Biotech: 5 transactions (3 Follow-Ons, 1 PIPE and 1 RD) totaling just over $600 Million

  • Med Tech: No Current Week Financings

2022:

  • 121 Biotech transactions totaling just under $15 Billion v. 2021 YTD: 267 Biotech transactions totaling just over $35 Billion

  • 40 Biotech transactions totaling just under $4 Billion in Q2 2022 v. Q2 2021: 64 Biotech transactions totaling just over $10 Billion

  • 10 Med Tech transactions totaling just over $800 Million v. 2021 YTD: 63 Med Tech transactions totaling just under $10 Billion

  • No Med Tech transactions in Q2 2022 v. Q2 2021: 13 Med Tech transactions totaling just over $1 Billion

Private Transactions:

  • Biotech: 222 US Transactions / 54 European Transaction

  • Med Tech: 136 US Transactions / 21 European Transactions



7 views1 comment

1 comentário


Gerald Brace
Gerald Brace
25 de out. de 2022

You're either a big fish (revenue/earnings generating co) or a little fish waiting to be gobbled up. Some little fish are yummy (good data/prospects) some are nasty (poor data/prospects). Discerning, which is which takes a team of scientists, like Lifesci

Curtir
bottom of page